Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment has ended, as the page now states no longer looking for participants. The update also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header along with a revision note for version 3.6.0.SummaryDifference0.3%

- Check16 days agoChange DetectedFooter revision updated from v3.5.4 to v3.5.5, indicating a newer page template version. This change does not modify the study details or visible content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the site's underlying system, with no visible changes to the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows the revision label as v3.5.3, indicating an updated build of the page.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision indicator was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedThe location label 'Padua, Italy 35128' was updated to 'Padova, Italy 35128' in the locations list.SummaryDifference0.0%

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.